Variable | Unadjusted HR (95% CI) | Adjusted HR (95% CI) |
---|---|---|
Sex | ||
Female | 1.00 (−) | NS† |
Male | 0.85 (0.61–1.18) | |
Age at first clinic visit (per 10-yr increment) | 1.55 (1.40–1.73) | 1.75 (1.53–2.00) |
Risk factor(s) for HIV infection | ||
Injection drug use + MSM | 1.00 (−) | 1.00 (−) |
Injection drug use only | 2.12 (1.39–3.24) | 2.75 (1.61–4.68) |
MSM only | 0.35 (0.23–0.55) | 0.50 (0.29–0.87) |
Other | 0.61 (0.41–0.90) | 0.68 (0.42–1.11) |
Unknown | 1.00 (0.58–1.73) | 0.81 (0.34–1.11) |
Baseline CD4 count (per increment of 100 cells/μL)‡ | 0.80 (0.75–0.85) | 0.85 (0.80–0.91) |
Baseline plasma viral load (log10 copies/mL)‡ | 1.12 (1.02–1.21) | NS† |
Visit constancy (first yr), % (as a continuous variable, per 20% increase) | 0.85 (0.77–0.94) | 0.87 (0.79–0.96) |
ART (ever during study period) | ||
No | 1.00 (−) | NS† |
Yes | 0.79 (0.52–1.19) |
Note: ART = antiretroviral therapy, CI = confidence interval, HR = hazard ratio, MSM = men who have sex with men, NS = not selected.
↵* Model excludes patients whose cause of death was unknown, those who did not have 1 year of data to assess visit constancy and those whose baseline CD4 count/plasma viral load were missing.
↵† Variable not included in adjusted HR.
↵‡ Most recent within 6 months of first clinic visit.